Newspaper icon
The latest issue of Financial Standard now available as an e-newspaper
READ NOW

Search Results

Showing 2181 - 2190 of 6869 results for "CRED"

A case for flexible asset allocation: First Sentier

ALLY SELBY  |  MONDAY, 27 APR 2020
Investment managers with fixed multi-asset allocations may have been better served by a flexible approach during the COVID-19 crisis. That's according to First Sentier Investors, who argue a flexible, dynamic multi-asset approach to investing can ...

Businesses urged to apply for JobKeeper

ELIZA BAVIN  |  MONDAY, 27 APR 2020
The Australian Small Business and Family Enterprise ombudsman Kate Carnell is concerned that many small businesses may not be applying for the JobKeeper scheme. Carnell said there is a concern from many small business owners that they cannot afford ...

COVID-19 will bite into credit ratings

BENJAMIN ONG  |  MONDAY, 27 APR 2020
Nothing focuses the mind as the choice between life and death. This choice has been thrust onto Planet Earth's population by the coronavirus pandemic. So much so, that men, women and children of the world are giving up - willingly or grudgingly ...

Future Fund falls 3.4% in March quarter

KANIKA SOOD  |  MONDAY, 27 APR 2020
Australia's sovereign wealth fund lost 3.4% or about $6 billion in the March quarter, and is in no hurry to revalue its unlisted assets out of cycle unlike some superannuation funds. The Future Fund stood at $162 billion at March end, after returning ...

Boutique manager taps former Challenger executive

HARRISON WORLEY  |  FRIDAY, 24 APR 2020
A liquid alternatives investment manager has added a new chief risk officer, hiring from Challenger. Sydney-based manager Darling Macro has appointed Mark Swan as its new chief risk officer. Swan joins the manager from Challenger, having served as senior ...

Markets react as antiviral drug disappoints

ALLY SELBY  |  FRIDAY, 24 APR 2020
News that a highly anticipated antiviral drug hoped to treat COVID-19 had flopped in human trials saw markets fall overnight. Originally reported by the Financial Times, the publisher said Gilead Sciences antiviral drug remdesivir did not reduce the ...

Morningstar acquires global ESG ratings house

ALLY SELBY  |  FRIDAY, 24 APR 2020
Morningstar has acquired a $288 million global ESG ratings and research house, in a bid to empower investors to make meaningful investment decisions. Morningstar acquired a 40% stake in Sustainalytics in 2017, and will now purchase the remaining 60% ...

The next big short

ALLY SELBY  |  THURSDAY, 23 APR 2020
Late last year, before extreme weather events battered the world, before COVID-19, The Big Short 's Michael Burry said he had found the next bubble: passive investments. Now, with asset prices trembling in the face of the pandemic, could there still ...

Multi-asset strategies key in COVID-19 crisis: First Sentier

ALLY SELBY  |  THURSDAY, 23 APR 2020
The ability to adjust to rapidly changing economic data is a key advantage of flexible multi-asset strategies during the COVID-19 crisis. In an investor update, First Sentier Investors co-head of multi-asset solution, Kej Somaia said that although market ...

Dealer group AFSL in limbo

ALLY SELBY  |  THURSDAY, 23 APR 2020
The suspension of MyPlanner Professional Services' AFSL is on ice as the Administrative Appeals Tribunal reviews ASIC's decision. It comes after the corporate watchdog suspended the advisory firm's AFS licence on February 12 on the grounds ...